Companies Directory

Unleashing the power of AI to propel companies ahead. That's our obsession at CellStrat. While other vendors pitch lofty AI dreams, we deliver tangible transformation. Our secret? Bespoke solutions finely tuned to clients' needs - whether it's revolutionizing legal work, energizing banking, or elevating healthcare. CellStrat's Generative AI product platform - ImagineView.com is a groundbreaking Generative AI Product Suite designed to revolutionize the way enterprises interact with their corporate databases. By leveraging advanced AI technologies, ImageineView enables Legal Firms, Banking, Financial Services & Insurance Companies, and Healthcare Organizations to extract valuable insights on demand, streamlining decision-making processes and enhancing productivity. Connect with us and let's build something phenomenal together!

Welcome to CellTec: Leaders in Engineering, Automation, and Safety Solutions! At CellTec, we're committed to revolutionising industries through cutting-edge engineering, innovative automation, and unwavering safety standards. Our Team: Comprised of forward-thinkers, engineers, and safety experts dedicated to pushing technological boundaries for safer, more efficient workplaces. Our Mission: Enhancing operational efficiency, mitigating risk, and fostering a safety-centric culture across diverse sectors including manufacturing, pharmaceuticals, renewables, biotechnology, and beyond. What We Offer: Advanced Automation Solutions: Tailored robotics integration for unparalleled efficiency. Precision Engineering: Seamless integration and optimal performance for your operations. Comprehensive Safety Solutions: Proactive risk management to safeguard your workforce and assets. Connect with Us: Join our journey to transform industries and shape the future of engineering, automation, and safety. Follow us for insights, updates, and industry-leading solutions!

Let’s reinvent the medicine we need Why are we here? Leading causes of death in the world Cardiovascular Diseases (CVDs) and Cancer are the leading causes of death and morbidity in the world, being considered as the major barriers to sustainable human development. WHO estimates that the number of new cases for each one of these diseases will increase by up to 70% in the next 20 years due to aging population. Currently Drug Discovery and Development process are time-consuming, expensive, with a high rate of failure and once drugs reach the market some still may fail due to the differences in populations. This rise far more concern in Latam developing countries which is the faster-aging region in the world and which accounts for only 5% of the populations studied in Drug development processes. What would happen if we speed up the search for life-saving drugs taking account the population differences and the major drawbacks since the beginning?. Well the chances boost up. This is why Cellter is born. This is why we’re here. All action is an opportunity. To learn. To change… Get better We’re a biotech startup combining AI-powered big data and drug design solutions to speed Up the search for diagnostics, medicines and therapies. We are solving the equation between time, costs, risk and efficiency. Creating revolutionary nano drugs to treat high incidence diseases and finding new therapies for unmet medical needs that will deliver life-changing innovations for all.

Celltest Biosciences is providing laboratory services for the pharmaceutical industry, with a track record for providing solutions with difficult molecular biology projects, antibody characterisation, and cell line development.

* CellTool – Raman laser microscopy: Single cell analysis- live cell laser trapping- label free- non destructive – digital microscopy - tissue and cell suspension - Metabolomic Fingerprint. * CellTool combines two Nobel Prize winning technologies in one system. Raman laser excites cellular components like DNA, proteins, lipids, sugars to produce a characteristic photonic spectrum that is specific for cell type and status. This offers many fields of application in precision medicine. • Cancer research: e.g. Cancer- non cancer classification, tumors aggressiveness, treatment response, spheroids, organoids. • Stem cell research: e.g. Cell differentiation, homogeneity, activation, contamination. • Regenerative medicine: e.g. 3D cell cultures, cells growth on scaffolds, cells transfection rate. • QC of cell therapeutic products: e.g. Skin grafts, blood bags, contaminations, immune cells activation. • Microbiology: e.g. Identification of bacterial species, fungi, yeast, other microorganisms. • Cell biology: e.g. Basic research, systems biology, live cells, single cell sorting. Our flagship product BioRam® is specifically designed for biologists and physicians and easy to use. It consists of an inverted digital microscopic platform equipped with: • Confocal Raman microscopic setup. • Motorized scanning stage. • Integrated (Laser) Optical Trap and sorting • Cell culture incubator (live cells measurements) • Confocal fluorescence configurations • Measurement software that is highly optimized for rapid data acquisition • Automatic data analysis software.

Harness the power of nature to create better products. CelluForce manufactures and commercialises cellulose nanocrystals and formulated nanocellulose solutions to help manufacturers around the world improve the environmental footprint and the technical performance of their products. Nanocrystalline cellulose is a new advanced biomaterial produced from wood cellulose, an abundant renewable material. CelluRods are high quality sulfated cellulose nanocrystals produced by CelluForce. They are biodegradable and have a very low carbon footprint. They are typically used in small amounts to improve product performance. CelluRods come in different grades to match your application requirements. CelluRods are available in powder or liquid form. The CelluForce team can help you integrate cellulose nanocrystals into existing and new products to achieve your sustainability and performance goals. CelluForce is the largest producer of cellulose nanocrystals in the world with a production capacity of 300 dried metric tonnes per year.

We are a consortium of entrepreneurs, scientists, pioneers, and foodies who see cellular agriculture as a way to make our food system more sustainable while allowing people to enjoy delicious, nutritious, and safe meat and dairy products.

Cellulant is Africa’s no.1 company in the payments & transfers category - FIntech Awards 2016. We are a PPISP (Payment Platform Infrastructure Service Provider) regulated by the Central Bank of Nigeria (CBN) and insured by Nigerian Deposit Insurance Corporation (NDIC).We provide the platform that powers the internet of payments with dominant market position across 12 Sub-Saharan countries – Kenya, Nigeria, Ghana, Uganda, Zambia, Mozambique, Tanzania, South Africa, Zimbabwe, Botswana and Malawi. Our payment infrastructure and ecosystem gives governments, donors, corporate businesses, merchants, retailers, agents and consumers access to payment instruments (cards, bank accounts, wallets & premium rated short-codes), stores of value (banks, mobile money accounts & prepaid cards/tokens), and payment channels (agents, apps, web portals & payment APIs for shopping cart checkout). We are Africa’s one-stop-shop for payments. When you connect to Cellulant, you get everything in payment.

BEHIND THE SCREENS Mit langjähriger Erfahrung und einem interdisziplinären Team entwickelt CELLULAR jeden Tag Konzepte und Lösungen für die Umsetzung maßgeschneiderter Produkte auf allen digitalen Screens. Als Digitalagentur übernehmen wir für unsere Kunden alle Schritte von der Beratung und Konzeption über das User Interface Design bis hin zu der technischen Umsetzung, dem Qualitätsmanagement und der strategischen Weiterentwicklung des Projekts. Dabei sind wir nicht an schnellen Lösungen interessiert, sondern erstellen als Sparringspartner in enger Zusammenarbeit umfassende Strategien, die auf dem digitalen Markt herausragen. Zu unseren Kunden zählen unter anderem ZDF, ORF, SRF, NZZ, ARD, Deutsche Welle, ECE, TUI Cruises, Unitymedia und die E-Plus Gruppe. CELLULAR ist inhabergeführt und beschäftigt rund 100 Mitarbeiter in Hamburg und Wien.